<- Go Home
Vital Therapies, Inc.
As of April 12, 2019, Vital Therapies, Inc. was acquired by Immunic AG, in a reverse merger transaction. Vital Therapies, Inc., a biotherapeutic company, focuses on developing cell-based therapies for the treatment of acute forms of liver failure. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is based in San Diego, California.
Market Cap
$25.5M
Volume
54.2K
Cash and Equivalents
$9.6M
EBITDA
-$26.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$390.00
52 Week Low
$6.04
Dividend
N/A
Price / Book Value
2.82
Price / Earnings
-0.70
Price / Tangible Book Value
2.82
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$27.1M
Return on Equity
157.86%
Return on Assets
-58.93
Cash and Short Term Investments
$9.6M
Debt
N/A
Equity
$9.0M
Revenue
N/A
Unlevered FCF
-$15.8M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium